OQROGet OQRO Pro
Insider trade

Danaher Corporation (DHR)Director sold ~$237K

Alan G Spoon, Director at Danaher Corporation, sold ~$237K of Danaher Corporation shares.

~$237K
Approx. value · 1,358 sh @ $174.67
124K
Holds after · shares reported
Traded
May 1, 2026
Filed
May 4, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 13, 2026FDAFDA device clearance: Access anti-HBc IgM
  2. Mar 16, 2026FDARecall: Access Total T4 Calibrator, Catalog No. 33805
  3. Mar 24, 2026FDAFDA device clearance: Access BNP II
  4. Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
  5. Mar 27, 2026CongressDisclosed purchase of DHR — reported range $1,001 - $15,000
  6. Apr 10, 2026FDAFDA device clearance: ABL90 FLEX PLUS System, safeCLINITUBES
  7. Apr 16, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
  8. Apr 21, 2026Company filing · Form 8-K · ResultsReported its results
  9. Apr 22, 2026Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
  10. Apr 29, 2026FDARecall: REMISOL Advance with Software Version 2.5 UDI-DI code: 15099590802073 The Normand Info REMISOL Advance Data Manager collects and manages data and workflow for…
  11. Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 6.7%
  12. May 1, 2026 · this disclosureInsiderDirector sold ~$237K of DHR shares in the open market

What came next

  1. May 1, 2026FDAFDA device clearance: ABL90 FLEX PLUS System
  2. May 1, 2026FDAFDA device clearance: ABL90 FLEX PLUS System
  3. May 5, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“On May 5, 2026, at the annual meeting of shareholders (the “Annual Meeting”) of Danaher Corporation (the “Company”), as further described in Item 5.07 below, the Company’s shareholders approved the Amended and Restated Danaher Corporation Omnibus Incentive Plan (the “Plan”).”
  4. Jun 3, 2026Company filing · Form 8-K · New debt, Other newsTook on new debt or obligations, and reported other company news
  5. Jun 26, 2026FDARecall: REF # D23354, MicroScan LabPro V5.03 Panel Update 11 DVD Kit (US) on the following instruments: - B1018-280 MicroScan autoSCAN-4 Instrument - B1018-283 MicroSc…
  6. Jun 26, 2026FDARecall: REF # D23352, MicroScan LabPro V5.03 Panel Update 11 (US), Electronic installed on the following instruments: - B1018-280 MicroScan autoSCAN-4 Instrument - B10…
  7. Jul 15, 2026FDARecall: Beckman Coulter DxC 500 AU Clinical Analyzer Modules using software version 1.5 or lower: 1) AU w/out ISE, Part Number C63519; 2) AU w/ISE, Part Number C63520;…
  8. Jul 15, 2026FDARecall: Beckman Coulter DxC 500i Clinical Analyzer Modules using software version 1.5 or lower: 1) DxC 500 AU Module w/ISE, DxC 500i, Part Number C63522; 2) DxC 500 AU…
  9. Jul 21, 2026Company filing · Form 8-K · ResultsReported its results
  10. Jul 31, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors (and 1 more item)“On August 3, 2026, Danaher Corporation (the “Company” or “Danaher”) announced that, effective as of October 1, 2026 (the “Effective Date”), the Board of Directors of the Company (the “Board”) has appointed Julie Sawyer Montgomery as President and Chief Executive Officer of the Company (the “CEO”).”
  11. Aug 7, 2026FDAFDA device clearance: Xpert Hemorrhagic Fever
  12. Aug 7, 2026FDAFDA device clearance: Aperio iQC DX Software
  13. Aug 7, 2026FDAFDA device clearance: Aperio GT 450 DX; Aperio GT 180 DX
  14. Aug 21, 2026Insider · 1 personInsiders: 3 sales (~$12.7M)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Danaher Corporation

For Danaher Corporation, OQRO holds 3 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports and 86 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DHR page.

Other recent filings by Alan G Spoon, Director

The full history of Alan G Spoon, Director is on the profile page.

How this filing works

Other disclosures at Danaher Corporation

Everything OQRO holds on this company is on its DHR page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data